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Care plans for people with Alzheimer’s disease
Intuitively a good idea, but hard to prove they are effective in practice
Lon S Schneider professor of psychiatry, neurology, and gerontology
University of Southern California Keck School of Medicine, 1510 San Pablo St, HCC 600, Los Angeles, California, 90033, USA
Inthelinkedclusterrandomisedtrial(doi:10.1136/bmj.c2466),
Nourhashemi and colleagues tested a specific care plan for
patients with Alzheimer’s disease to determine whether it
improved activities of daily living and delayed admission to
institutional care or death.
1 The authors randomised specialty
memoryclinicsinFrancetoprovidepatientswiththeusualcare
given at the clinic or a special dementia care plan, which
consisted of twice yearly assessments based around a checklist
and clinician initiated interventions as needed. The checklist
assessedeachpatient’sandcaregiver’sknowledgeoftheillness;
the caregiver’s health; the need for home help and respite care;
thepatient’snutritionalstatus,functionaldependency,gait,need
for exercise training, behavioural symptoms, depression status,
sleeping pattern, and car driving risk; any legal issues; and the
decision to admit to institutional care. The interventions
consisted mainly of low intensity verbal or written education
and counselling for the caregiver and patient and conveying
recommendationstothepatient’sprimarycarepractitioner.The
trial found no significant difference in outcomes at two years.
Guideline based interventions for dementia care are
recommended by many professional organisations, although it
isoftennotclearwhoshouldcarryouttheseinterventions.
2Care
planmodelsorguidelinesoftenhavethestatedaimsofdelaying
disease progression and functional decline, improving quality
of life, controlling symptoms, and providing comfort.
3 4 In
Nourhashemi and colleagues’ study specialists used checklists
for assessment and went through educational procedures with
patients and caregivers. Yet, with the possible exception of the
nutritional counselling, this may not have been very different
fromwhatspecialistsdoasamatterofcourse.Patientsprobably
received a similar level of care to that recommended by many
guidelines issued by professional organisations, in particular
thosefromEuropeandementiaspecialists.
5Theauthorssuggest
that both the care plan group and the usual care group received
better care and had better outcomes because they were treated
in memory clinics rather than general practices. However,
without a comparison group from general practice we don’t
really know whether the specialty clinics provided more
specialised and effective care.
Few, if any, randomised trials have looked at care plans per se
(as compared with drug treatments, specific non-drug
interventions, or caregiver interventions) that aim to improve
outcomes for patients with dementia.
2 Some fairly specific
interventions directed at caregivers seem to improve behaviour
but not other outcomes. For example, in one collaborative care
model, nurse practitioners using ongoing standardised
interventions, with caregivers focusing on environmental and
behavioural management, reduced behavioural problems over
one year but did not improve function or cognition.
6 In another
trial,individualisedpsychosocialinterventionsreducedagitation
but had no effect on quality of life.
7 Structured interventions
provided by social workers aimed at caregivers delayed
admission to institutional care compared with usual care at a
New York Alzheimer’s disease research centre.
8 An intensive
care management programme provided by social workers that
includedin-homeassessmentsincreasedadherencetotreatment
guidelines, services, and the quality of life of patients and
caregivers.
9 These approaches focused more on patients’
potentially disruptive behaviours and required additional
clinicianresourcesthatmostdoctors,includingthoseatspecialty
clinics, may not be able to access. Moreover, care plans and
interventions that seemed most effective needed a higher
intensity of intervention and greater resources.
2 10
Thetrialwaslimitedinhavingonlythreemainoutcomes—daily
activities, admission to institutional care, and death—and by
being unable to assess exactly what was done in the treatment
asusualcontrolclinics.Anotherlimitationwasthatinterventions
were more frequent at baseline, when doctors first applied the
checklist and did a thorough evaluation, but then became less
frequent over time. This is somewhat counterintuitive because
patients would be expected to receive more interventions as
they inevitably progress, especially in view of their increased
behavioural disturbances. This phenomenon may also indicate
that the care plan—straightforward as it is—was not simple to
implement. Nevertheless, the trial provides an important basis
from which to assess the feasibility and effectiveness of care
plansdeliveredbydoctors.Italsohighlightstheneedtodevelop
effective comprehensive care plans that can be integrated into
practice.
The lack of a significant effect of the care plan in Nourhashemi
and colleagues’ trial should not deter clinicians from providing
care that is consistent with this care plan and with evidence
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4 5 The study highlights that specialists need
to build a contract with patients and their families to provide
thebestqualityofcare;reviewcaremoreoften;andcollaborate
with other care providers including primary care practitioners,
social workers, and nurse specialists.
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